International Biotechnology Trust plc
Share this pagePrint this page

Portfolio Analysis

31 August 2014

Summary

 

IBT Portfolio NAV (m)

215

Number of Portfolio Companies

89

Quoted Investments

63

Unquoted Investments

26

 

Quoted / Unquoted Split
NAV by Geography

Quoted

92%

United States / Canada

89%

Unquoted

8%

Europe

11%

Total

100% 

Total

100%

 

 

 

 

 

NAV by Subsector
NAV by Market Capitalisation

 

 

Therapeutics

79%

Large-Cap (>$10bn)

50%

Medical Devices

4%

Mid-Cap (>$1bn, <$10bn)

30%

Specialty Pharma

11%

Small-Cap (<$1bn)

12%

Life Sciences, Tools

6%

Unquoted

8%

Total100%

Total

100%

 

 

NAV by Development Phase
NAV by Portfolio Profitability

 

 

 

Marketed

65%

Profitable

62%

Regulatory

6%

Turning Profitable 2014

6%

Phase 3

17%

Unprofitable

32%

Phase 2

8%

Total

100%

Phase 1

1%

 

Other

3%

 

Total

100%